Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Remazol black B MeSH Supplementary Concept Data 2025


MeSH Supplementary
Remazol black B
Unique ID
C063421
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C063421
Entry Term(s)
2,7-naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis(2-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl)-, sodium salt (1:4)
4-amino-5-hydroxy-3,6-bis((4-((2- (sulfooxy)ethyl)sulfonyl)phenyl)azo)-2,7- naphthalenedisulfonic acid tetrasodium salt
C.I. reactive black
CI reactive black 5
CI-20505
RB5 cpd
Remazol black B, disodium salt
reactive black 5
reactive black B
tetrasodium 4-amino-5-hydroxy-3,6-bis((4-((2- (sulphonatooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-2,7- disulphonate
Registry Numbers
O0HDY58362
86144-37-8
0
Related Numbers
17095-24-8
86144-37-8
Heading Mapped to
*Naphthalenesulfonates
Frequency
254
Note
RN given refers to the tetrasodium salt
Source
J Allergy Clin Immunol 1990;85(3):642
Date of Entry
1990/04/20
Revision Date
2016/11/01
Remazol black B Preferred
Remazol black B, disodium salt Narrower
RB5 cpd Narrower
CI-20505 Narrower
page delivered in 0.002s